Literature DB >> 11489986

Signaling alterations in activation-induced nonresponsive CD8 T cells.

E L Tham1, M F Mescher.   

Abstract

Costimulation-dependent production and autocrine use of IL-2 by activated CD8 T cells results in initial clonal expansion, but this is transient. The cells quickly become anergic, unable to produce IL-2 in response to Ag and costimulation, irrespective of the form of costimulation. This activation-induced non-responsiveness (AINR) differs from "classical" anergy in that it results despite the cells receiving both signal 1 and signal 2. AINR cells can still proliferate in response to exogenous IL-2, but can no longer produce it. Other TCR-mediated events including cytolytic function and IFN-gamma production are not affected in the AINR state. To characterize the mechanism(s) responsible for lack of IL-2 production in CD8 T cells in the AINR state, microspheres bearing immobilized anti-TCR Abs or peptide-MHC complexes, B7-1, and ICAM-1 were used to provide well-defined stimuli to the cells. Comparison of normal and AINR cells revealed that in AINR cells extracellular signal-regulated kinase (ERK) is upregulated more transiently, Janus kinase activation is substantially reduced, and activation of p38 is eliminated. PMA and ionomycin restored proliferation and IL-2 production in AINR cells, indicating a signaling defect upstream of Ras and protein kinase C. Inhibitors of ERK (PD98059) and of p38 kinase (SB202190) blocked IL-2 mRNA expression and proliferation of both peptide-MHC/B7-1/ICAM-1-stimulated normal cells and PMA/ionomycin-stimulated AINR cells. Together these results demonstrate that activation of at least ERK and p38 is essential for IL-2 production by CD8 T cells and that up-regulation of these mitogen-activated protein kinases, along with Janus kinase, is defective in AINR cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489986     DOI: 10.4049/jimmunol.167.4.2040

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Authors:  Shoji Asakura; Daigo Hashimoto; Shuichiro Takashima; Haruko Sugiyama; Yoshinobu Maeda; Koichi Akashi; Mitsune Tanimoto; Takanori Teshima
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

3.  Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.

Authors:  Michael Uhlin; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

4.  T helper lymphocytes rescue CTL from activation-induced cell death.

Authors:  Richard Kennedy; Esteban Celis
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 5.  Molecular mechanisms for adaptive tolerance and other T cell anergy models.

Authors:  Seeyoung Choi; Ronald H Schwartz
Journal:  Semin Immunol       Date:  2007-04-02       Impact factor: 11.130

Review 6.  Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.

Authors:  Matthew F Mescher; Pujya Agarwal; Kerry A Casey; Christopher D Hammerbeck; Zhengguo Xiao; Julie M Curtsinger
Journal:  Semin Immunol       Date:  2007-03-26       Impact factor: 11.130

Review 7.  Shaping successful and unsuccessful CD8 T cell responses following infection.

Authors:  Maureen A Cox; Allan J Zajac
Journal:  J Biomed Biotechnol       Date:  2010-03-31

8.  Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency.

Authors:  M D Köller; H P Kiener; M Aringer; W B Graninger; S Meuer; Y Samstag; J S Smolen
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 9.  Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.

Authors:  Matthew F Mescher; Flavia E Popescu; Michael Gerner; Chris D Hammerbeck; Julie M Curtsinger
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

10.  Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.

Authors:  Dolgor Baatar; Purevdorj B Olkhanud; Valerie Wells; Fred E Indig; Livio Mallucci; Arya Biragyn
Journal:  Brain Behav Immun       Date:  2009-06-09       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.